RNA-INTERFERENZ-VERMITTELTE HEMMUNG VON TMPRSS6

European patent · EP3607068 · In force

Register entry

Publication number
EP3607068
Application number
EP18715705
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 5, 2018
Published
Feb 12, 2020
Granted
Nov 2, 2022
Protection ends at the latest
Apr 4, 2038
Next annual fee due
Apr 30, 2027
IPC classes
C12N 15/113 (2010.01)
A61K 31/713 (2006.01)
Priority
EP 17165007 05.04.2017
EP 17201405 13.11.2017
PCT application
PCT/EP2018/058764 05.04.2018
PCT publication
WO2018/185240 11.10.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. Sep 13, 2023

    Change

    Published in Swissreg on 13.09.2023

  5. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  6. Dec 27, 2022

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 27.12.2022

  7. Nov 2, 2022

    Granted

    Published in Swissreg on 02.11.2022

Parties

Holder

Silence Therapeutics GmbH

Robert-Rössle-Strasse 10, 13125 Berlin, DE

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

FRAUENDORF, Christian

13127 Berlin, DE

BETHGE, Lucas

14473 Potsdam, DE

HAUPTMANN, Judith

13125 Berlin, DE

DAMES, Sibylle

13125 Berlin, DE

WEINGÄRTNER, Adrien

13125 Berlin, DE

SCHAEPER, Ute

13125 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.